###begin article-title 0
A Regulatory Role for NBS1 in Strand-Specific Mutagenesis during Somatic Hypermutation
###end article-title 0
###begin p 1
Conceived and designed the experiments: QP AT. Performed the experiments: TS LD AK XL JL CB SP. Analyzed the data: QP DD LD. Contributed reagents/materials/analysis tools: KC AT AG GE. Wrote the paper: QP.
###end p 1
###begin p 2
###xml 993 1000 993 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1228 1229 1228 1229 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 1439 1440 1439 1440 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 1131 1139 <span type="species:ncbi:9606">patients</span>
###xml 1267 1275 <span type="species:ncbi:9606">patients</span>
###xml 1466 1474 <span type="species:ncbi:9606">patients</span>
Activation-induced cytidine deaminase (AID) is believed to initiate somatic hypermutation (SHM) by deamination of deoxycytidines to deoxyuridines within the immunoglobulin variable regions genes. The deaminated bases can subsequently be replicated over, processed by base excision repair or mismatch repair, leading to introduction of different types of point mutations (G/C transitions, G/C transversions and A/T mutations). It is evident that the base excision repair pathway is largely dependent on uracil-DNA glycosylase (UNG) through its uracil excision activity. It is not known, however, which endonuclease acts in the step immediately downstream of UNG, i.e. that cleaves at the abasic sites generated by the latter. Two candidates have been proposed, an apurinic/apyrimidinic endonuclease (APE) and the Mre11-Rad50-NBS1 complex. The latter is intriguing as this might explain how the mutagenic pathway is primed during SHM. We have investigated the latter possibility by studying the in vivo SHM pattern in B cells from ataxia-telangiectasia-like disorder (Mre11 deficient) and Nijmegen breakage syndrome (NBS1 deficient) patients. Our results show that, although the pattern of mutations in the variable heavy chain (VH) genes was altered in NBS1 deficient patients, with a significantly increased number of G (but not C) transversions occurring in the SHM and/or AID targeting hotspots, the general pattern of mutations in the VH genes in Mre11 deficient patients was only slightly altered, with an increased frequency of A to C transversions. The Mre11-Rad50-NBS1 complex is thus unlikely to be the major nuclease involved in cleavage of the abasic sites during SHM, whereas NBS1 might have a specific role in regulating the strand-biased repair during phase Ib mutagenesis.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 386 387 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 670 673 668 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Chaudhuri1">[1]</xref>
###xml 674 677 672 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-PanHammarstrom1">[3]</xref>
Mammalian organisms require two types of DNA recombination in order to produce functional antibody encoding genes. The first, V(D)J recombination, mediates assembly of the variable domains of the immunoglobulin (Ig) heavy and light chains in pre-B cells. In the second, class switch recombination (CSR), the constant region gene of the mu heavy chain (Cmu) is replaced by a downstream CH gene, resulting in a change from IgM to IgG, IgE, or IgA production. Both types of recombination require double-strand breaks (DSBs) as intermediates, and mechanisms for genomic stability, especially the non-homologous end-joining (NHEJ) pathway(s), are utilized in these processes [1]-[3].
###end p 4
###begin p 5
###xml 335 338 335 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Muramatsu1">[4]</xref>
###xml 441 444 441 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Rada1">[5]</xref>
###xml 446 449 446 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-DiNoia1">[6]</xref>
###xml 674 677 674 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Bemark1">[7]</xref>
###xml 775 778 775 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Faili1">[8]</xref>
###xml 779 783 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Neuberger1">[10]</xref>
###xml 952 956 952 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Neuberger1">[10]</xref>
Somatic hypermutation (SHM), where point mutations are introduced at a high rate into the Ig variable (V) genes, is another important process that shapes the Ig repertoire. SHM and CSR can occur independently in the germinal center but are both initiated by a single B cell-specific factor, activation-induced cytidine deaminase (AID) [4], probably through deamination of deoxycytidine (dC) to deoxyuridine (dU) residues within the Ig locus [5], [6]. The initial lesion in the V genes and switch (S) regions are, however, resolved differently, as DSBs seem not to be prominent intermediates in SHM and one of the core NHEJ factors, DNA-PKcs, is dispensable for this process [7]. Conversely, single strand breaks (SSBs) or single strand nicks appear to be associated with SHM [8]-[10]. At least two pathways, base excision repair and mismatch repair, have been implicated in processing of the dU: deoxyguanosine (dG) lesions in the V regions during SHM [10]. However, the mechanism by which they result in a mutagenic, rather than a faithful repair remains elusive. Furthermore, these pathways are also involved in CSR and the way in which they are regulated and coordinated to mediate SHM or CSR is still not well understood.
###end p 5
###begin p 6
###xml 130 133 130 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Rada1">[5]</xref>
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Imai1">[11]</xref>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-DiNoia2">[12]</xref>
###xml 513 517 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Demple1">[13]</xref>
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Robson1">[14]</xref>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Xanthoudakis1">[15]</xref>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Hadi1">[16]</xref>
###xml 685 690 685 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APEX2</italic>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Ide1">[17]</xref>
###xml 1070 1074 1069 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Guikema1">[18]</xref>
###xml 579 583 <span type="species:ncbi:10090">mice</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
###xml 1017 1021 <span type="species:ncbi:10090">mice</span>
It is evident that the base excision repair pathway operating in SHM and CSR is largely dependent on uracil-DNA glycosylase (UNG) [5], [11], through its uracil excision activity [12]. It is not known, however, which endonuclease acts in the subsequent step, i.e. recognizes the abasic sites generated by UNG and converts them to SSBs. The obvious candidate is an apurinic/apyrimidinic endonuclease (APE or APEX), which functions in the conventional base excision repair. In mammalian cells, APE1 is the major APE [13], [14] and it is essential for early embryonic development in mice [15]. A second APE, APE2, has also been identified [16] and mice with a targeted inactivation of the APEX2 gene show thymic atrophy and reduced number of B cells [17], suggesting that APE2 may have unique functional properties in the lymphoid system that cannot be compensated by APE1. Recently, Guikema et al have suggested that both APEs are involved in CSR, based on observation that CSR and DSBs in Smu are moderately reduced in mice deficient in APE2 or haploinsufficient for APE1 [18]. A potential role for these factors in SHM has, however, not been identified.
###end p 6
###begin p 7
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Larson1">[19]</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-DAmours1">[20]</xref>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Lavin1">[21]</xref>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Luo1">[22]</xref>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Zhu1">[24]</xref>
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Stewart1">[25]</xref>
###xml 682 686 682 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Varon1">[26]</xref>
###xml 820 824 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Lahdesmaki1">[27]</xref>
###xml 826 830 826 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Pan1">[28]</xref>
###xml 1060 1064 1060 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Lahdesmaki1">[27]</xref>
###xml 1066 1070 1066 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Pan1">[28]</xref>
###xml 1221 1225 1221 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Kracker1">[29]</xref>
###xml 1227 1231 1227 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-ReinaSanMartin1">[30]</xref>
###xml 1411 1415 1411 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Yabuki1">[31]</xref>
###xml 1537 1541 1537 1541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Larson1">[19]</xref>
###xml 1559 1567 1559 1567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1649 1653 1649 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Larson1">[19]</xref>
###xml 1786 1793 1786 1793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 487 493 <span type="species:ncbi:9606">humans</span>
###xml 719 727 <span type="species:ncbi:9606">patients</span>
###xml 948 956 <span type="species:ncbi:9606">patients</span>
###xml 1169 1174 <span type="species:ncbi:10090">mouse</span>
###xml 1342 1347 <span type="species:ncbi:9606">human</span>
###xml 1885 1893 <span type="species:ncbi:9606">patients</span>
An alternative candidate, the Mre11-Rad50-NBS1 (MRN) complex, has recently been proposed to compete with APE1 for cleavage of abasic sites and to direct a mutagenic pathway [19]. This multi-subunit nuclease is required for telomere maintenance, cell cycle checkpoint signaling, DNA replication, meiotic recombination and repair of DSBs by homologous recombination and/or NHEJ [20], [21]. In mice, disruption of any subunit of the MRN complex results in embryonic lethality [22]-[24]. In humans, mutations in the genes encoding Mre11 and NBS1 result in two rare chromosomal instability syndromes: ataxia-telangiectasia-like disorder (ATLD) and Nijmegen breakage syndrome (NBS) [25], [26]. By studying B cells from these patients, we have previously shown that CSR is less efficient when either Mre11 or NBS1 is deficient [27], [28]. In addition, skewed mutation patterns at the switch recombination junctions have been observed in both ATLD and NBS patients, suggesting that the MRN complex may be involved in repair/editing of DNA breaks/ends in the S regions [27], [28]. The requirement of NBS1 for efficient CSR has also been demonstrated by analyzing NBS1-deficient mouse B cells using a conditional knockout strategy [29], [30]. In addition to its role in CSR, the MRN complex has recently been implicated in SHM, as hypermutation in the human B cell line Ramos is accelerated by ectopic expression of NBS1 [31]. Furthermore, Mre11, rather than APE1, has been shown to be associated with rearranged Ig genes in hypermutating B cells [19]. Moreover, in an in vitro assay, Mre11/Rad50 cleaves at abasic sites within single-stranded regions of DNA [19]. To test whether the MRN complex is indeed involved in SHM and the possibility that it might act downstream of UNG, we analyzed the in vivo SHM patterns in the Ig locus in cells from ATLD (Mre11 deficient) and NBS (NBS1 deficient) patients.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 16 17 16 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
SHM pattern in VH3-23-Cgamma transcripts in ATLD patients
###end title 9
###begin p 10
###xml 109 110 109 110 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 220 227 216 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g001">Fig. 1A</xref>
###xml 274 275 270 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 408 415 404 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002482-t001">Table 1</xref>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
###xml 304 312 <span type="species:ncbi:9606">patients</span>
###xml 530 537 <span type="species:ncbi:9606">patient</span>
RNA was prepared from peripheral blood mononuclear cells (PBMC) from 4 ATLD patients. In total, 34 distinct VH3-23-Cgamma clones were generated and all clones were mutated (2-50 bp substitutions/clone, average 22.1 bp) (Fig. 1A). Overall, the frequency of mutations in the VH3-23 genes derived from ATLD patients varied from 5.9% to 8.9%, which is similar to that found in controls (3.4%-9.3%, average 6.9%; Table 1). The ratio of replacement vs. silent (R/S) mutations in the CDRs (CDR1-2) and FR (FR1-3) was also similar in the patient and control groups.
###end p 10
###begin title 11
###xml 40 41 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
Pattern of mutations introduced in the VH3-23-Cgamma transcripts.
###end title 11
###begin p 12
###xml 130 131 130 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 286 287 286 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 580 581 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 633 634 633 634 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 905 906 903 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 981 982 979 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 991 992 989 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1252 1253 1226 1227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 1300 1301 1274 1275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 151 159 <span type="species:ncbi:9606">patients</span>
###xml 549 557 <span type="species:ncbi:9606">patients</span>
###xml 1416 1424 <span type="species:ncbi:9606">patients</span>
A). Pie charts demonstrate the proportion of clones carrying the indicated number of mutations. B). Distribution of mutations in VH3-23 in ATLD or NBS patients (above the zero line) and in controls (below the zero line). Nucleotides are numbered from the third base of codon 10 of the VH3-23 coding region. The percentage of mutations at each position (number of mutations at each position / total number of mutation) is plotted and the major hotspots in controls are highlighted. Several positions that show significantly more mutations in the NBS patients are also indicated. **p<0.01. C). Nature of the base substitutions in the VH3-23 genes. The germline sequence used for comparison contains 21.4% A, 31.7% G, 21.4% T and 25.5% C. Correction: values presented in the column were corrected to represent sequences with equal amounts of the four nucleotides. Statistical analysis was performed using chi2 test. Numbers that are significantly different from controls are bolded. *p<0.05; **p<0.01. upward arrow, significantly increased; downward arrow, significantly decreased. D). Percent distribution of each type of nucleotide substitution. Individual substitutions are paired together with their complementary mutations. Mutations in ATLD or NBS VH3-23 sequences were compared with the control VH3-23 transcripts. Stars indicate that the proportion of a given substitution when it is significantly different in patients as compared to the controls.
###end p 12
###begin title 13
###xml 14 15 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Mutations in VH3-23-Cgamma transcripts from PMBC from NBS and ATLD patients.
###end title 13
###begin p 14
a) CDR, complementary determining region; FR, framework region.
###end p 14
###begin p 15
b) Too few mutations to give a reliable ratio.
###end p 15
###begin p 16
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 69 73 69 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-PanHammarstrom4">[60]</xref>
c) The VH3-23 sequences from controls have been described previously [60].
###end p 16
###begin p 17
###xml 38 39 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 112 119 112 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g001">Fig. 1B</xref>
###xml 529 530 527 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 537 538 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
###xml 332 340 <span type="species:ncbi:9606">patients</span>
###xml 490 498 <span type="species:ncbi:9606">patients</span>
The distribution of mutations in the VH3-23 sequence in ATLD patients was similar to that observed in controls (Fig. 1B) and there was no significant difference in targeting of any of the 271 positions between patients and controls. Furthermore, no major differences were found in the nature of base pair substitutions between ATLD patients (753 mutations) and normal controls (750 mutations), except that there was a small, albeit significant, increase of A to C transversions in the ATLD patients (8.8 vs. 5.3% in controls, chi2 test, p<0.01).
###end p 17
###begin p 18
###xml 266 267 266 267 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 270 271 270 271 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 279 280 279 280 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 346 347 346 347 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 349 357 349 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s001">Table S1</xref>
###xml 637 644 637 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002482-t002">Table 2</xref>
###xml 649 657 649 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s003">Table S3</xref>
###xml 690 691 690 691 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 699 700 699 700 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 781 785 781 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Rogozin1">[32]</xref>
###xml 866 867 866 867 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 895 896 893 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 903 904 901 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1315 1316 1313 1314 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 92 100 <span type="species:ncbi:9606">patients</span>
###xml 614 622 <span type="species:ncbi:9606">patients</span>
###xml 1008 1016 <span type="species:ncbi:9606">patients</span>
###xml 1344 1352 <span type="species:ncbi:9606">patients</span>
To search for a potential cause for the increased frequency of A to C transversions in ATLD patients, we analyzed the frequency of mutations in each of the 64 possible trinucleotide combinations. Significantly increased targeting of the A residues was observed in AGA, CAA and CGA, whereas significantly decreased targeting of A was noticed in CTA (Table S1). These trinucleotides are neither related to the AID targeting (WRC/GYW) (W, A or T; R, A or G; Y, C or T) motifs, nor the SHM hotspot motifs (RGYW/WRCY), and no difference in targeting of the A residues within these motifs could be observed between ATLD patients and controls (Table 2 and Table S3). Two of these trinucleotides, CAA and CTA, are related to the previously described SHM hotspots (WA/TW) for A/T mutations [32]. There was indeed a significantly decreased targeting of the A residues in the TA motifs (9.2% vs. 13.3%, chi2 test, p<0.05) and a small, but not significant, increase in targeting of the AA motifs (7.2% vs. 5.3%) in ATLD patients. The frequency of A to C transversions was, however, increased in both the TA and AA motifs (35% vs. 21% of total A mutations within the TA and 44% vs. 23% within the AA motifs), and also outside these motifs (34% vs. 22%). We thus conclude that the frequency and distribution of mutations in the VH regions are normal in ATLD patients. The general pattern of base substitutions was slightly altered, with an increased frequency of A to C transversions. This alteration was, however, not associated with differential targeting of any of the known SHM hotspots.
###end p 18
###begin title 19
###xml 50 51 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 61 62 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
Number of mutations at AID targeting hotspots in VH3-23 and JH4 intronic sequences
###end title 19
###begin title 20
###xml 16 17 16 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
SHM pattern in VH3-23-Cgamma transcripts in NBS patients
###end title 20
###begin p 21
###xml 92 93 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 217 224 213 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g001">Fig. 1A</xref>
###xml 262 263 258 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 414 421 410 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002482-t001">Table 1</xref>
###xml 611 618 607 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002482-t001">Table 1</xref>
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 291 299 <span type="species:ncbi:9606">patients</span>
###xml 507 515 <span type="species:ncbi:9606">patients</span>
RNA samples from 6 NBS patients (NBS1-6) were subsequently analyzed. In total, 74 distinct VH3-23-Cgamma clones were obtained and a majority of these clones were mutated (2-28 bp substitutions/clone, average 11.2 bp; Fig. 1A). The frequency of mutations in the VH3-23 genes derived from NBS patients varied from 2.4% to 5.2%, with an average of 4.1%, which was lower than in the controls (3.4%-9.3%, average 6.9%, Table 1). The ratio of R/S mutations in the CDRs and FRs was within the normal range in most patients, except in NBS6, where nearly all the observed mutations in the CDR regions were replacements (Table 1).
###end p 21
###begin p 22
###xml 185 186 185 186 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 217 218 217 218 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 238 245 238 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g001">Fig. 1B</xref>
###xml 408 409 406 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 416 417 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 552 553 550 551 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 562 563 560 561 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 569 570 567 568 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 578 579 576 577 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 610 617 608 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g001">Fig. 1B</xref>
###xml 831 832 827 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 839 840 835 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 910 911 904 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 918 919 912 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 926 933 920 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g001">Fig. 1C</xref>
###xml 1024 1025 1016 1017 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1032 1033 1024 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1115 1116 1105 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1123 1124 1113 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1131 1145 1121 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g001">Fig. 1C and 1D</xref>
###xml 1379 1380 1367 1368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1387 1388 1375 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 360 368 <span type="species:ncbi:9606">patients</span>
###xml 685 693 <span type="species:ncbi:9606">patients</span>
###xml 1085 1093 <span type="species:ncbi:9606">patients</span>
###xml 1228 1236 <span type="species:ncbi:9606">patients</span>
The distribution of mutations observed in NBS patients was largely similar to that found in normal controls, with major hot spots of mutation at previously described RGYW/WRYC motifs (AGCT at position 72 and 129 and AGCA at position 150; Fig. 1B). However, a slight increase, albeit significant, number of mutations was observed at these three hotspots in NBS patients (11.2% vs. 8.0% of total mutations, chi2 test, p<0.05). In addition, we also found a significantly increased targeting at a few positions that are normally not highly mutated in the VH genes (AGCT, TAG, and AAC at positions 84, 135 and 211; Fig. 1B). Furthermore, the general pattern of base substitution in the NBS patients (829 mutations) was somewhat different from that in controls (750 mutations), with significantly more transversions (49.3% vs. 44.3%, chi2 test, p<0.05) and substitutions occurring at G residues (41.4% vs. 35.6%, chi2 test, p<0.05; Fig. 1C). These were mainly due to an increased frequency of G transversions (20.4% vs. 14.3%, chi2 test, p<0.01), especially G to C transversions, in the NBS patients (16.6% vs. 10.9%, chi2 test, p<0.01; Fig. 1C and 1D). There seems to be a gain of strand polarity at G/C pairs in the V region in NBS patients, where the G residues on the top (non-transcribed, coding) strand were preferred targets for mutations (G/C ratio 1.9 vs. 1.4 in controls; chi2 test, p<0.05). The strand preference at A/T pairs was, however, not affected (A/T ratio 1.7 vs. 1.8 in controls).
###end p 22
###begin p 23
###xml 179 180 179 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 240 241 240 241 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 436 444 436 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s002">Table S2</xref>
###xml 516 517 516 517 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 520 521 520 521 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 525 526 525 526 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 535 536 535 536 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 545 546 545 546 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
###xml 568 576 <span type="species:ncbi:9606">patients</span>
To search for a potential cause for the increased targeting of G residues in NBS patients, we first analyzed the sequences surrounding individual mutated bases (-2 to +2) in the VH3-23 genes. The preferred target motif for G mutation was TAGYW for both patients and controls, confirming the known hotspots for G mutations (RGYW/WRCY). We subsequently performed a similar analysis as described above for the targeting of trinucleotides (Table S2). Significantly increased targeting of the G residues was observed in AGC, GCA, GCT and TAG in the VH3-23 genes in the NBS patients.
###end p 23
###begin p 24
###xml 333 339 333 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g002">Fig. 2</xref>
###xml 344 351 344 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002482-t002">Table 2</xref>
###xml 512 513 512 513 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</underline>
###xml 519 520 519 520 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 532 533 532 533 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 705 706 705 706 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 876 883 876 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002482-t002">Table 2</xref>
###xml 926 927 926 927 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</underline>
###xml 991 992 991 992 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 1178 1179 1176 1177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1186 1187 1184 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1324 1325 1322 1323 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 1441 1449 1439 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s003">Table S3</xref>
###xml 323 331 <span type="species:ncbi:9606">patients</span>
###xml 813 821 <span type="species:ncbi:9606">patients</span>
###xml 1103 1111 <span type="species:ncbi:9606">patients</span>
###xml 1418 1426 <span type="species:ncbi:9606">patients</span>
As the first three trinucleotides are all related to the AID targeting (WRC/GYW) and/or SHM hotspot motifs for G/C mutations (RGYW/WRCY), we subsequently analyzed the frequency of G mutations within, or outside, these motifs. A significantly higher number of G mutations was indeed observed in the WRC or GYW motifs in NBS patients (Fig. 2 and Table 2), whereas G residues outside these motifs were targeted equally (11.3% vs. 11.1% of total mutations in controls). The G mutations occurring in the overlapping WRC and GYW motifs (WGCW) were, however, counted twice when analyzing the WRC and GYW motifs separately. When this was taken into account, an increased targeting of the G nucleotides within the GYW motifs (including those within the overlapping motifs) could explain most of the difference between NBS patients and controls in terms of targeting of the G residues (Table 2), and most of the G mutations within the WRC motifs were actually located within the palindromic sequence WGCW. Furthermore, within the GYW motifs, the proportion of G to C transversions was significantly higher in NBS patients (38.3% vs. 27.1% of the total G mutations within these motifs, chi2 test, p<0.05). Similar results were obtained when analyzing the RGYW/WRCY motifs, where an increased targeting of the G nucleotides within the RGYW motifs (including the "dual" motif AGCT) could explain most of the difference between NBS patients and controls (Table S3).
###end p 24
###begin title 25
###xml 53 54 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
Frequency of mutations within the WRC/GYW motifs in VH3-23 sequences.
###end title 25
###begin p 26
###xml 105 113 <span type="species:ncbi:9606">patients</span>
Stars indicate that the frequency of mutations at a given position when it is significantly different in patients as compared to controls.
###end p 26
###begin p 27
###xml 101 102 101 102 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 136 137 136 137 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 316 317 316 317 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 323 324 323 324 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 327 334 327 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002482-t002">Table 2</xref>
###xml 336 342 336 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g002">Fig. 2</xref>
###xml 347 355 347 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s003">Table S3</xref>
###xml 421 422 421 422 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 507 508 507 508 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 587 588 587 588 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 186 194 <span type="species:ncbi:9606">patients</span>
###xml 462 470 <span type="species:ncbi:9606">patients</span>
###xml 602 610 <span type="species:ncbi:9606">patients</span>
It is interesting to note that while, on the top strand, the G residues at the first position of the GYW or the second position of the RGYW motifs were significantly more mutated in NBS patients, no alteration in the rate of mutations was noted in the corresponding C residues at the reverse complementary motifs (WRC or WRCY; Table 2, Fig. 2 and Table S3). The C residues within the AID hotspot in the bottom strand (3'-CRW-5') seemed to be more mutated in NBS patients, while those in the top strand (5'WRC-3') were not affected. The altered pattern of base pair substitutions in the VH genes in NBS patients may thus arise from asymmetric targeting of AID, or linked repair steps.
###end p 27
###begin p 28
###xml 157 158 157 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 258 259 258 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 490 497 490 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002482-t001">Table 1</xref>
###xml 548 549 548 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 778 779 776 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 786 787 784 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 848 849 844 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 856 857 852 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 891 899 887 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s004">Table S4</xref>
###xml 955 956 951 952 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 980 981 974 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 988 989 982 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1023 1024 1017 1018 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 1048 1049 1040 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1056 1057 1048 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1179 1180 1171 1172 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 1186 1187 1178 1179 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 1405 1406 1397 1398 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 11 19 <span type="species:ncbi:9606">patients</span>
###xml 465 473 <span type="species:ncbi:9606">patients</span>
###xml 635 643 <span type="species:ncbi:9606">patients</span>
###xml 872 879 <span type="species:ncbi:9606">patient</span>
###xml 1111 1119 <span type="species:ncbi:9606">patients</span>
###xml 1305 1313 <span type="species:ncbi:9606">patients</span>
###xml 1420 1428 <span type="species:ncbi:9606">patients</span>
###xml 1510 1518 <span type="species:ncbi:9606">patients</span>
As the NBS patients are younger (2-16 years old) than the controls (14-30 years old), we subsequently studied the frequency and pattern of mutations in the VH3-23 genes from an additional group of controls, aged 1-8 years. The frequency of mutations in the VH3-23 genes derived from the second group of controls varied from 1.9% to 4.6%, with an average of 3.1%, which is lower as compared to the first group of controls (average 6.9%), but comparable with the NBS patients (average 4.1%) (Table 1). The patterns of base pair substitutions in the VH3-23 genes derived from the two groups of controls were largely similar. When the NBS patients were compared with the second group of controls, we could confirm that there were significantly more G mutations (41.4% vs. 35.9%, chi2 test, p<0.05), especially G to C transversions (16.6% vs. 12.0%, chi2 test, p<0.01), in the patient sequences (Table S4). Furthermore, the G residues at the first position of GYW (29.3% vs. 23.0%, chi2 test, p<0.01) or the second position of RGYW (22.9% vs. 18.4%, chi2 test, p<0.05) motifs were significantly more targeted in the patients whereas targeting of the corresponding C residues in the WRC or WRCY motifs was not affected. We thus conclude that the frequency of mutations is still within the normal range when NBS patients are compared to controls with a similar age. The nature of base pair substitutions in the VH genes in NBS patients is however altered, and these changes are not associated with the younger age of patients.
###end p 28
###begin title 29
###xml 21 22 21 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Mutation pattern in JH4 intronic regions in NBS patients
###end title 29
###begin p 30
###xml 65 66 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 270 271 270 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 301 302 301 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 412 413 412 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 709 710 709 710 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 1097 1098 1097 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 342 350 <span type="species:ncbi:9606">patients</span>
###xml 426 433 <span type="species:ncbi:9606">patient</span>
###xml 435 439 <span type="species:ncbi:9606">NBS6</span>
###xml 520 528 <span type="species:ncbi:9606">patients</span>
###xml 787 795 <span type="species:ncbi:9606">patients</span>
###xml 890 897 <span type="species:ncbi:9606">patient</span>
###xml 1011 1019 <span type="species:ncbi:9606">patients</span>
###xml 1170 1178 <span type="species:ncbi:9606">patients</span>
The number of mutations (n = 7) obtained from nonproductive NBS VH3-23 rearrangements was not sufficient for further analysis. To exclude the possibility that the altered mutation pattern in NBS cells was a result of selection bias introduced by studying the expressed VH genes only, we analyzed the JH4 intronic sequences in 7 NBS (NBS6-12) patients and 10 controls. We were able to obtain DNA samples from CD27+ PBMC in one patient (NBS6) and nine controls, where fresh blood samples were available. For the remaining patients and controls, DNA samples were obtained from PBMC. More than 1750 clones were screened and 652 clones were fully sequenced. After removing clones with the same V(D)J junctions or JH4 intronic sequences, 279 and 175 distinct clones were obtained from the NBS patients and controls respectively. There was a marked variation in mutation frequency both within the patient group (0.02%-0.70%) and controls (0.00%-2.21%), although, in general, the rate of mutations was lower in the NBS patients (average 0.45% vs. 1.48% in controls). However, taking into account that CD27+ cells were enriched in the controls, the frequency of mutations in NBS patients was still comparable to controls.
###end p 30
###begin p 31
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 304 305 302 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 312 313 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 368 369 364 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 376 377 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 409 410 405 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 600 607 596 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g003">Fig. 3A</xref>
###xml 612 613 606 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 620 621 614 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 630 631 624 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 643 644 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 749 750 743 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 807 813 801 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g003">Fig. 3</xref>
###xml 1005 1006 997 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1013 1014 1005 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1037 1038 1029 1030 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 1236 1237 1228 1229 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 1248 1255 1240 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002482-t002">Table 2</xref>
###xml 1284 1285 1276 1277 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 1296 1304 1288 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s003">Table S3</xref>
###xml 1451 1452 1443 1444 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 1458 1459 1450 1451 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 1476 1483 1468 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002482-t002">Table 2</xref>
###xml 1488 1490 1480 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s003">S3</xref>
###xml 1545 1546 1537 1538 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 1607 1608 1599 1600 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
###xml 950 957 <span type="species:ncbi:9606">patient</span>
###xml 1335 1343 <span type="species:ncbi:9606">patients</span>
###xml 1506 1514 <span type="species:ncbi:9606">patients</span>
The pattern of base substitutions in the JH4 intronic regions derived from NBS patients (386 mutations) was again different from that in controls (797 mutations) and we confirmed that, as in the VH3-23 transcripts, there were significantly more transversions occurring at G residues (18.9% vs. 13.4%, chi2 test, p<0.01) and G mutations altogether (38.1% vs. 28.9%, chi2 test, p<0.01). However, unlike in the VH3-23 transcripts, increased numbers of all types of G mutations (G to C, G to T and G to A) were observed, although none of the individual counts reached a statistically significant degree (Fig. 3A; chi2 test, p = 0.08, p = 0.10 and p = 0.11 respectively). In addition, there were also significantly fewer A to G substitutions in the NBS JH4 intronic sequences as compared to those from controls (Fig. 3). The preference for G, rather than C, residues on the top strand, a gain of strand polarity at G/C pairs, was again notable in the NBS patient samples (G/C ratio 1.4 vs. 0.9 in controls; chi2 test, p<0.05), and as in the VH sequences, the strand preference for A/T pairs was not affected (A/T ratio 1.5 vs. 1.6 in controls). Furthermore, we could see a significant trend where the G residues in the first position of the GYW motifs (Table 2) or the second position of RGYW motifs (Table S3) were more mutated in the NBS patients, whereas no difference in targeting of the corresponding C residues in the reverse complementary motifs (WRC or WRCY) was observed (Table 2 and S3). Thus, in NBS patients, the mutation pattern in the JH4 intronic sequences largely recaptures the features in the VH regions, where an increased number of the G, but not C, mutations are observed in SHM and/or AID hotspots.
###end p 31
###begin title 32
###xml 40 41 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
Pattern of mutations introduced in the JH4 intronic sequences.
###end title 32
###begin p 33
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 323 324 321 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 399 400 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 409 410 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 576 584 <span type="species:ncbi:9606">patients</span>
A). Nature of the base substitutions in the JH4 intronic genes. The germline sequence used for comparison contains 17.9% A, 32.1% G, 17.5% T and 32.5% C. Correction: values presented in the column were corrected to represent sequences with equal amounts of the four nucleotides. Statistical analysis was performed using chi2 test. Numbers that are significantly different from controls are bolded. *p<0.05; **p<0.01. B). Percent distribution of each type of nucleotide substitution. Stars indicate that the proportion of a given substitution is significantly different in NBS patients as compared to that in controls.
###end p 33
###begin title 34
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Characteristics of the CDR3 in B cells from ATLD and NBS patients
###end title 34
###begin p 35
###xml 139 140 139 140 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 150 151 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 401 409 401 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s005">Table S5</xref>
###xml 564 565 564 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 666 667 666 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 674 675 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 682 690 682 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s005">Table S5</xref>
###xml 756 757 756 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
###xml 829 837 <span type="species:ncbi:9606">patients</span>
###xml 944 952 <span type="species:ncbi:9606">patients</span>
Diversity in the CDR3 region in clones derived from the ATLD and NBS patients was also analyzed. The CDR3 contains contributions from the VH, D, and JH gene segments and nucleotides added by TDT. The majority of analyzable clones were in-frame rearrangements (27 of 30 ATLD clones and 69 of 72 NBS clones). The average length of the CDR3 in the ATLD and NBS clones was similar to those from controls (Table S5). The length of the N regions and the number of P nucleotides in the ATLD clones were comparable to the controls. The average length of the N2 region (D-JH junctions) was, however, significantly shorter in the NBS clones as compared to controls (Student's t test, p<0.05; Table S5) but no significant difference in the length of the N1 regions (VH-D junction) or the frequency of P nucleotides was observed between NBS patients and controls. We thus conclude that the pattern of V(D)J coding joints are largely normal in ATLD and NBS patients.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Yabuki1">[31]</xref>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Luo1">[22]</xref>
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Zhu1">[24]</xref>
###xml 550 555 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mre11</italic>
###xml 559 562 559 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBN</italic>
###xml 789 793 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Digweed1">[33]</xref>
###xml 795 799 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Taylor1">[34]</xref>
###xml 921 928 921 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 933 934 933 934 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 499 507 <span type="species:ncbi:9606">patients</span>
###xml 968 976 <span type="species:ncbi:9606">patients</span>
###xml 1036 1044 <span type="species:ncbi:9606">patients</span>
It has previously been suggested that the MRN complex participates in all three AID-initiated processes that diversify the Ig genes; CSR, SHM and gene conversion. Support for the latter two mechanisms is, however, indirect, and based on experiments using ectopic expression of NBS1 in B cell lines [31]. "Null" mutations in the gene encoding any subunit of the MRN complex result in embryonic lethality in mice [22]-[24], suggesting that this complex is essential in mammals. Cells from ATLD or NBS patients, who carry "hypomorphic" mutations in the Mre11 or NBN gene, have been used as an alternative system to analyze the functional properties of the MRN complex in DNA damage signaling and DNA repair, as these cells have either no, or markedly reduced levels of the wild type proteins [33], [34]. In this study, we therefore assessed the role of the MRN complex in SHM, by analyzing the mutational spectrum generated in vivo in VH genes in cells from ATLD and NBS patients. Largely normal frequencies of mutations in both groups of patients suggest that the complex is not essential for SHM.
###end p 37
###begin p 38
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Larson1">[19]</xref>
###xml 448 452 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Larson1">[19]</xref>
###xml 739 743 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Delbos1">[35]</xref>
###xml 1027 1041 1017 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g001">Fig. 1C and 1D</xref>
###xml 1159 1163 1147 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Delbos1">[35]</xref>
###xml 1716 1721 1704 1709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mre11</italic>
###xml 1878 1882 1866 1870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Stewart1">[25]</xref>
###xml 2002 2006 1988 1992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Masuda1">[36]</xref>
###xml 2229 2235 2211 2217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g004">Fig. 4</xref>
###xml 2539 2543 2521 2525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Kanno1">[37]</xref>
###xml 753 761 <span type="species:ncbi:9606">patients</span>
###xml 1388 1396 <span type="species:ncbi:9606">patients</span>
###xml 1572 1580 <span type="species:ncbi:9606">patients</span>
###xml 1632 1640 <span type="species:ncbi:9606">patients</span>
###xml 1790 1798 <span type="species:ncbi:9606">patients</span>
The first two components of the MRN complex, Mre11 and Rad50, have been shown to have abasic site-lyase activity, with a preference for single stranded DNA [19]. The DNA ends produced by Mre11/Rad50 cleavage cannot directly prime new DNA synthesis by polymerase beta (pol beta), which carries out high-fidelity repair. Mre11 has therefore been proposed to compete with APE1 for cleavage of abasic sites and to direct a mutagenic pathway during SHM [19]. This hypothesis would predict that Mre11 is involved in the UNG dependent pathway, which is mainly responsible for generation of phase 1b mutations (G/C transversions) but, together with polymerase eta (pol eta), also generates a small proportion of phase II mutations (A/T mutations) [35]. In ATLD patients (Mre11 deficient), we did observe a perturbed mutation pattern, with a small increase of A to C transversions (phase II). The number of G to C transversions (phase Ib) was, however, only slightly increased and the difference did not reach statistical significance (Fig. 1C and 1D). As the UNG-pol eta pathway probably only serves as a backup for the MSH2-dependent pathway in phase II mutagenesis [35], one would not expect a major change in the mutation pattern or total mutation load at A/T bases. We would, however, expect a more pronounced change in the rate of G/C transversions (decreased rather than increased) in ATLD patients. Thus, Mre11 is unlikely to be the major enzyme used to cleave the abasic sites during SHM. Nevertheless, the increased rate of A to C transversions was only observed in ATLD patients and, notably, these changes were more prominent in patients ATLD1 and ATLD2, who carry homozygous 1897 C>T (R633stop) mutations in the Mre11 gene. The truncated Mre11 protein expressed in cells from these two patients show weaker interaction with Rad50 as compared with those from ATLD3 and ATLD4 [25]. As pol eta is responsible for most of the A to G and A to T substitutions, but only about 50% of the A to C mutations [36], an increased frequency of the latter could indicate a lower activity of pol eta and/or a higher activity of other polymerases. Thus, the possibility remains that there is a subtle defect in the UNG-Mre11-pol eta pathway (Fig. 4). APE1 and APE2 remain the best candidates for cleavage of the abasic sites during SHM, although direct evidence for their involvement is still missing and potential participation of other, less well-characterized, AP endonucleases such as PALF (PNK and APTX-like FHA protein) also needs to be excluded [37].
###end p 38
###begin title 39
Hypothetical model for strand-biased mutagenic repair during SHM.
###end title 39
###begin p 40
###xml 172 175 172 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Rada1">[5]</xref>
###xml 1095 1099 1095 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Unniraman1">[62]</xref>
AID is believed to initiate SHM through deamination of the dC residues, probably on both strands. In phase Ia, replication over dU, without repair, creates G/C transitions [5]. In phase Ib, removal of the uracil by UNG produces an abasic site that can be cleaved by an APE and subsequently repaired by low-fidelity polymerases, leading to transitions as well as transversions at G/C residues. Alternatively, mutations at G/C residues might arise if a bypass DNA polymerase inserts a base opposite to an abasic site before the lesion has been recognized by APE. The mismatch repair pathway may contribute a small fraction of phase Ib mutation although the exact mechanism is not known. During phase Ib, NBS1 promotes error-free base-excision repair and inhibits the abasic site bypass DNA synthesis or low-fidelity base excision repair, if the abasic site is located in the bottom strand. In phase II, mutations are introduced at adjacent positions, predominantly at nearby A/T pairs, mainly through a MSH2/MSH6 triggered, error-prone, patch repair process. Based on the study by Unniraman et al [62], the top-strand deaminated C residues contribute to most of the mutations at A/T residues. The low-fidelity base excision pathway, together with pol eta, may contribute a small proportion of the A/T mutations and Mre11 might be involved in this minor pathway. Base alterations are shown in red. AP, abasic site.
###end p 40
###begin p 41
###xml 898 901 898 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Rada1">[5]</xref>
###xml 903 907 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Xue1">[38]</xref>
###xml 953 957 953 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Xiao2">[39]</xref>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
The skewed mutation pattern in NBS1 deficient patients has not been observed in any mouse or human disease model. The alteration (increased G mutations) is closely associated with SHM and/or AID hotspots and causes a G over C strand bias. It is possible that, in the normal situation, NBS1 facilitates generation of mutations from the C residues on the top strand or prevents mutations of the deaminated C residues on the bottom strand. Potentially, in the presence of NBS1, the top strand (non-transcribed, coding) is more targeted by AID than the bottom strand (transcribed, non-coding), or maybe a deaminated C residue, located on the top strand, is processed differently from one located on the bottom strand (mutagenically repaired or faithfully repaired). Based on data from UNG and Msh2 double knockout mice, it has been suggested that AID deaminates the top and bottom strands equally well [5], [38]. If this is true (there is still some debate [39]), NBS1 is more likely to be involved in, or regulating, a strand-specific mutagenic repair step after the initial AID targeting.
###end p 41
###begin p 42
###xml 104 105 104 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Yabuki1">[31]</xref>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Yabuki1">[31]</xref>
###xml 490 491 490 491 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 612 613 612 613 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 651 658 651 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 343 351 <span type="species:ncbi:9606">patients</span>
When NBS1 was overexpressed in the human B cell line Ramos, an increased frequency of mutations in the VH genes was observed [31]. The mutation spectrum was also altered, with proportionally more C than G mutations [31]. This may suggest that NBS1 facilitates generation of mutations from the C residues in the top strand. However, in our NBS patients (NBS defective), the mutation frequency in general is largely normal, and although an increased number of G mutations was observed in the GYW motifs (AID hotspots in the bottom strand), the frequency of mutations at the C residues in the top-strand hotspot (WRC) was not altered. Thus, based on our in vivo data, NBS1 is more likely to influence the outcome of deaminated C residues in the bottom strand (faithfully repaired or mutated), rather than to promote generation of mutations from the top strand.
###end p 42
###begin p 43
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Boddy1">[40]</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Trenz1">[43]</xref>
###xml 347 353 347 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g004">Fig. 4</xref>
###xml 779 783 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Jansen1">[44]</xref>
###xml 941 942 941 942 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 1133 1139 1133 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g004">Fig. 4</xref>
###xml 1542 1546 1542 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Delbos1">[35]</xref>
###xml 1643 1647 1643 1647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Longerich1">[45]</xref>
###xml 1649 1655 1649 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002482-g004">Fig. 4</xref>
###xml 956 964 <span type="species:ncbi:9606">patients</span>
How might then NBS1 be regulating the mutagenic repair in the bottom strand? One possibility is that by regulating the S phase checkpoint and interacting with the DNA replication machinery [40]-[43], NBS1 inhibits abasic site bypass DNA synthesis by certain translesion synthesis polymerases, if the abasic sites are located in the bottom strand (Fig. 4). When NBS1 is defective, these polymerases will be able to bypass the DNA lesion in the bottom strand as well, by incorporating a base opposite an abasic site. Rev1 could be one such polymerase, which inserts a C opposite an abasic site. In its absence, the C to G transversions are completely absent on the top strand, but only partially reduced on the bottom strand, suggesting that it has a preference for the top strand [44]. Thus, a loss of strand preference of Rev1 could explain the "net" increase of G to C transversions (i.e. C to G transversions on the bottom strand) in the VH genes in NBS patients. Alternatively, following cleavage of the abasic site by APE, NBS1 inhibits the action of low-fidelity polymerases, if the abasic site is located on the bottom strand (Fig. 4). In addition to the above hypothesis that NBS1 is involved in, or regulating the "post-UNG" events during base-excision repair, the possibility that it interacts with the mismatch repair pathway should also be considered. The MSH2-dependent mismatch repair pathway can recognize the dU:dG lesions and it is responsible for generating small proportion of the G/C mutations, including G/C transversions [35]. Perhaps NBS1 can direct the choice of which of the strands is being removed by mismatch repair [45] (Fig. 4). Regardless of the mechanism involved, our data suggests that transversions at G/C residues (phase Ib mutations) are also generated in a strand-biased manner. NBS1 may be regulating this process by promoting error-free repair on the bottom strand.
###end p 43
###begin p 44
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Maser1">[46]</xref>
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Maser1">[46]</xref>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Difilippantonio1">[47]</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Stewart1">[25]</xref>
###xml 705 709 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Fernet1">[48]</xref>
###xml 16 24 <span type="species:ncbi:9606">patients</span>
###xml 295 302 <span type="species:ncbi:9606">patient</span>
###xml 509 517 <span type="species:ncbi:9606">patients</span>
###xml 657 665 <span type="species:ncbi:9606">patients</span>
Most of the NBS patients included in this study carry a deletion mutation (675del5), which was originally regarded as a null mutation. Later, it was shown that in addition to the predicted NBS1 p26 protein, through alternative translation, another truncated protein, NBS1 p70 is produced by the patient cells [46]. This protein lacks the N-terminal FHA and BRCT domains but can still associate with Mre11/Rad50 and is probably responsibe for the cell viability [46], [47]. As the G/C mutation pattern in ATLD patients is largely normal, the role of NBS1 in SHM is probably uncoupled from Mre11. As the level of NBS1 is also decreased in cells from the ATLD patients included in this study (ATLD1-4) [25], [48], the moderately increased rate of G to C transversions noted might be a consequence of a reduced level of NBS1, rather than deficiency of Mre11.
###end p 44
###begin p 45
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Lahdesmaki1">[27]</xref>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Lahdesmaki1">[27]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Lahdesmaki1">[27]</xref>
###xml 543 544 543 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 814 818 814 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Berkovich1">[49]</xref>
###xml 820 824 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Kitagawa1">[50]</xref>
###xml 1028 1032 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Pan1">[28]</xref>
###xml 1034 1038 1034 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Lumsden1">[51]</xref>
###xml 1039 1043 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Yan1">[54]</xref>
###xml 1061 1064 1061 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Bemark1">[7]</xref>
###xml 1066 1070 1066 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-PanHammarstrom3">[55]</xref>
###xml 79 86 <span type="species:ncbi:9606">patient</span>
###xml 108 116 <span type="species:ncbi:9606">patients</span>
###xml 299 307 <span type="species:ncbi:9606">patients</span>
###xml 564 572 <span type="species:ncbi:9606">patients</span>
The mutation pattern at the CSR junctions was altered in both the NBS and ATLD patient groups [27]. In ATLD patients, there were fewer base substitutions due to transitions and, most strikingly, the substitutions that occurred most often in controls, C to T transitions, never occurred [27]. In NBS patients, base substitutions were only observed at the G/C nucleotides, with a preference for transitions [27]. These peculiar patterns of base substitutions at CSR junctions were, however, quite different from the patterns we observed in the VH regions from these patients. Thus, although the MRN complex might be involved in both CSR and SHM, the underlying mechanisms could be quite different. For instance, the role of the MRN complex during CSR could be attributed to its activity in the ATM signaling pathway [49], [50], or through its interaction with the NHEJ pathway. This would, however, not explain the role of the MRN complex in SHM, as the ATM dependent signaling and the classical NHEJ pathway are critical for CSR [28], [51]-[54], but not for SHM [7], [55].
###end p 45
###begin p 46
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 232 233 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
###xml 248 256 <span type="species:ncbi:9606">patients</span>
In summary, the SHM mutation pattern in the VH genes in NBS patients was altered, with a significantly increased number of G transversions occurring in the SHM and/or AID targeting hotspots. The general pattern of mutations in the VH genes in ATLD patients was slightly altered, with an increased frequency of A to C transversions. Mre11 is thus unlikely to be the major enzyme used to cleave abasic sites, whereas NBS1 might have an Mre11-independent role in regulating the strand-specific mutagenic repair process during SHM, although the actual mechanism remains elusive.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient material
###end title 48
###begin p 49
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Stewart1">[25]</xref>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mre11</italic>
###xml 199 206 199 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002482-t001">Table 1</xref>
###xml 523 526 523 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBN</italic>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Gennery1">[56]</xref>
###xml 839 843 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Gregorek1">[57]</xref>
###xml 985 989 985 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Gennery1">[56]</xref>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
###xml 177 185 <span type="species:ncbi:9606">patients</span>
###xml 246 254 <span type="species:ncbi:9606">patients</span>
###xml 293 300 <span type="species:ncbi:9606">patient</span>
###xml 302 306 <span type="species:ncbi:9606">NBS6</span>
###xml 332 340 <span type="species:ncbi:9606">patients</span>
###xml 390 398 <span type="species:ncbi:9606">Children</span>
###xml 567 575 <span type="species:ncbi:9606">patients</span>
###xml 668 672 <span type="species:ncbi:9606">NBS6</span>
###xml 835 838 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 845 849 <span type="species:ncbi:9606">NBS6</span>
The study included 4 ATLD patients from two independent families and the clinical details of these patients have been described previously [25]. The mutations in Mre11 in these patients are shown in Table 1. The study also included 11 Polish NBS patients (NBS1-5, NBS7-12) and 1 Pakistani NBS patient (NBS6). The diagnosis of these patients was carried out in the respective centers in the Children's Memorial Health Institute (Poland) and the Newcastle General Hospital (UK). The truncating 5-bp deletion (657del5) in the NBN gene is present in a homozygous form in patients NBS1-5 and NBS7-12, whereas a homozygous nonsense mutation (1089C>A) has been identified in NBS6 [56]. NBS1-5 and 7-12 showed reduced serum levels of IgG or IgG subclasses and/or IgA and severely impaired specific antibody responses after vaccination against HBV [57]. NBS6 (p1 in the original report) had hypogammaglobulinaemia and the tetanus and HiB antibody response after immunization was poor or absent [56]. The institutional review board at the Karolinska Institute approved the study.
###end p 49
###begin title 50
###xml 40 41 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
RNA isolation and PCR amplification of VH3-23-Cgamma transcripts
###end title 50
###begin p 51
###xml 187 214 183 210 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTCCTTGACCAGGCAGCCCAG-3&#8242;</named-content>
###xml 507 508 485 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 538 539 512 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 548 554 522 528 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tctaga</underline>
###xml 545 581 519 555 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-<underline>tctaga</underline>GGCTGAGCTGGCTTTTTCTTGTGG-3&#8242;</named-content>
###xml 601 607 571 577 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gtcgac</underline>
###xml 596 633 566 603 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ca<underline>gtcgac</underline>AAGA CCGATGGGCCCTTGGTGG-3&#8242;</named-content>
###xml 702 705 672 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 721 722 691 692 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 740 743 710 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 974 978 922 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vent</italic>
###xml 1032 1035 980 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfu</italic>
###xml 8 16 <span type="species:ncbi:9606">patients</span>
###xml 282 290 <span type="species:ncbi:9606">patients</span>
For NBS patients and controls, total RNA was extracted from PBMC using RNeasy RNA purification kits (Qiagen, Germany) and first-strand cDNA synthesis was performed with a CgammaA primer (5'-GTCCTTGACCAGGCAGCCCAG-3') using a cDNA synthesis kit (Pharmacia, Uppsala, Sweden). For ATLD patients, total RNA was extracted from B cells using the Ultraspectrade mark RNA isolation system (Biotex). cDNA was synthesized using a Revers-iT cDNA synthesis kit (Abgenetrade mark). The primers used for amplification of VH3-23-Cgamma transcripts were VH3-23 (5'-tctagaGGCTGAGCTGGCTTTTTCTTGTGG-3') and CgammaB (5'-cagtcgacAAGA CCGATGGGCCCTTGGTGG-3'). The oligonucleotides contained a restriction site, (underlined, a Xba I site in the VH3-23 primer and a Sal I site in the CgammaB primer) for directional cloning of the PCR products. Amplification was performed in 35 cycles, each cycle consisting of 94degreesC 50 sec, 62degreesC 1 min and 72degreesC 1 min. High fidelity DNA polymerases Vent (New England BioLabs, Hertfordshire, England, GB) or Pfu (Fermentas Life Sciences, Burlington, Canada) were used for the amplification.
###end p 51
###begin title 52
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
PCR amplification of JH4 intronic region sequences
###end title 52
###begin p 53
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 177 178 177 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 259 260 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 363 364 363 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Faili2">[58]</xref>
###xml 398 401 398 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 409 412 409 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 438 439 438 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 449 450 449 450 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 633 634 633 634 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 728 731 728 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 766 769 766 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pwo</italic>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-PanHammarstrom3">[55]</xref>
###xml 868 871 868 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfu</italic>
###xml 933 934 933 934 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 1058 1067 1058 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF13B</italic>
###xml 962 970 <span type="species:ncbi:9606">patients</span>
PBMCs were isolated by density gradient centrifugation and CD27+ cells were separated from PBMCs using CD27 MicroBeads and a MiniMACS Separator (Miltenyi Biotec, CA, USA). The JH4 intronic regions were PCR amplified from genomic DNA prepared from PBMC or CD27+ PBMC (when fresh blood samples were available) using a FR3 consensus primer and a primer upstream of JH5 as described previously [58]. A Xba I or a Sal I site was added in the JH4-FR3 or JH5 primer for directional cloning of the PCR products. A long PCR kit (Expand Long Template PCR System Kit, Roche Diagnostics Scandinavia, Bromma, Sweden) was employed to amplify the JH4 intronic region in the first set of controls. This system uses an enzyme mixture containing Taq DNA polymerase and a proofreading Pwo DNA polymerase. The PCR error was estimated to be 2/10000 bp [55]. A high fidelity DNA polymerase Pfu (Fermentas Life Sciences) was used in amplifications of the JH4 intronic regions from NBS patients and a second set of controls. Genomic DNA from several individuals with known germline TNFRSF13B sequences were used to assess the fidelity of this polymerase. Independent PCR products were cloned, and mutations were shown to be introduced at a rate of less than 1/10000 bp in 37 clones analyzed (1 error of the 18027 bp sequenced). There was no significant difference in frequency of mutations and base substitution pattern in the two sets of controls (190 and 425 mutations respectively) and they were thus merged as one group.
###end p 53
###begin title 54
###xml 13 14 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 27 28 23 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
Analysis of VH-Cgamma and JH4 clones
###end title 54
###begin p 55
###xml 210 211 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 232 233 228 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 244 245 240 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 385 386 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 445 449 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Giudicelli1">[59]</xref>
###xml 464 465 456 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 511 512 499 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 521 522 509 510 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 660 661 648 649 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
The PCR products were purified and cloned into the Bluescript II KS (+) vector (Stratagene, La Jolla, USA) and transformed into JM 109 competent cells. The resulting clones were screened by PCR amplification (VH3-23 and CgammaB or JH4-FR3 and JH5) and positive clones were sequenced by an automated fluorescent sequencer in MWG (Ebersberg, Germany) or in Macrogen (Seoul, Korea). The VH-Cgamma sequence analysis was performed by IMGT/V-QUEST () [59] to align the VH-CgammaB sequences to their closest germline VH, D and JH segment counterparts. The immunoglobulin V(D)J junctional sequences were analyzed by the IMGT/JunctionAnalysis tool (). The analysis on JH4 intronic sequences was performed using the LASERGENE software package (DNASTAR, Madison, WI, USA).
###end p 55
###begin p 56
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-PanHammarstrom4">[60]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002482-Spencer1">[61]</xref>
###xml 140 141 140 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 150 151 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 205 206 205 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 215 216 215 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 588 589 586 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Sequence motifs surrounding mutated bases and trinucleotide targeting were determined as previously described [60], [61]. Briefly, mutated VH3-23 or JH4 intron sequences were aligned beneath the germline VH3-23 or JH4 intron region gene and a raw test file of the alignment was created. This file was imported into a Microsoft Excel spreadsheet and computations of the number of each type of nucleotide substitution and the composition of the flanking sequences around these substitutions were performed using macros in Excel (Visual Basic). Computations of percentage differences and chi2 analysis were also performed using Excel.
###end p 56
###begin title 57
Online Supplemental Material
###end title 57
###begin p 58
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s001">Table S1</xref>
###xml 13 15 13 15 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s002">S2</xref>
###xml 105 113 105 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s003">Table S3</xref>
###xml 179 180 179 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 190 191 190 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 238 246 238 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s004">Table S4</xref>
###xml 363 371 363 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002482.s005">Table S5</xref>
###xml 422 423 422 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 215 223 <span type="species:ncbi:9606">patients</span>
###xml 298 306 <span type="species:ncbi:9606">patients</span>
###xml 465 473 <span type="species:ncbi:9606">patients</span>
Table S1 and S2 show the number of mutations at each base of all trinucleotides in ATLD or NBS patients. Table S3 shows the frequency of mutations within the RGYW/WRCY motifs in VH3-23 and JH4 intronic sequences in patients and controls. Table S4 shows the nature of base pair substitutions in NBS patients and controls with younger ages (Control II, 1-8 years). Table S5 shows the characteristics of the CDR3 regions in VH3-23-Cgamma transcripts from ATLD and NBS patients.
###end p 58
###begin title 59
Supporting Information
###end title 59
###begin p 60
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Number of mutations at each base of all trinucleotidesa in ATLD patients
###end p 60
###begin p 61
(0.09 MB PDF)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin p 63
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Number of mutations at each base of all trinucleotidesa in NBS patients
###end p 63
###begin p 64
(0.08 MB PDF)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin p 66
Number of mutations at SHM G/C mutation hotspots in VH3-23 and JH4 intronic sequences
###end p 66
###begin p 67
(0.06 MB PDF)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
Comparison of the nature of base substitutions in the VH3-23
###end p 69
###begin p 70
(0.07 MB PDF)
###end p 70
###begin p 71
Click here for additional data file.
###end p 71
###begin p 72
###xml 83 91 <span type="species:ncbi:9606">patients</span>
Characteristics of the CDR3 regions in VH3-23-Cgamma transcripts from ATLD and NBS patients
###end p 72
###begin p 73
(0.06 MB PDF)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
We are indebted to Professors L. Hammarstrom and M. Neuberger for critically reading the manuscript.
###end p 75
###begin title 76
References
###end title 76
###begin article-title 77
Class-switch recombination: interplay of transcription, DNA deamination and DNA repair.
###end article-title 77
###begin article-title 78
Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus.
###end article-title 78
###begin article-title 79
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 59 64 <span type="species:ncbi:9606">human</span>
Class switch recombination: a comparison between mouse and human.
###end article-title 79
###begin article-title 80
Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.
###end article-title 80
###begin article-title 81
###xml 99 103 <span type="species:ncbi:10090">mice</span>
Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice.
###end article-title 81
###begin article-title 82
Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase.
###end article-title 82
###begin article-title 83
Somatic hypermutation in the absence of DNA-dependent protein kinase catalytic subunit (DNA-PK(cs)) or recombination-activating gene (RAG)1 activity.
###end article-title 83
###begin article-title 84
AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line.
###end article-title 84
###begin article-title 85
The generation of antibody diversity through somatic hypermutation and class switch recombination.
###end article-title 85
###begin article-title 86
Somatic hypermutation at A.T pairs: polymerase error versus dUTP incorporation.
###end article-title 86
###begin article-title 87
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination.
###end article-title 87
###begin article-title 88
Dependence of antibody gene diversification on uracil excision.
###end article-title 88
###begin article-title 89
###xml 59 64 <span type="species:ncbi:9606">human</span>
Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: definition of a family of DNA repair enzymes.
###end article-title 89
###begin article-title 90
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 129 136 <span type="species:ncbi:562">E. coli</span>
Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease III) mutants.
###end article-title 90
###begin article-title 91
###xml 85 89 <span type="species:ncbi:10090">mice</span>
The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice.
###end article-title 91
###begin article-title 92
###xml 7 12 <span type="species:ncbi:9606">human</span>
###xml 42 58 <span type="species:ncbi:562">Escherichia coli</span>
Second human protein with homology to the Escherichia coli abasic endonuclease exonuclease III.
###end article-title 92
###begin article-title 93
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Growth retardation and dyslymphopoiesis accompanied by G2/M arrest in APEX2-null mice.
###end article-title 93
###begin article-title 94
APE1- and APE2-dependent DNA breaks in immunoglobulin class switch recombination.
###end article-title 94
###begin article-title 95
MRE11/RAD50 cleaves DNA in the AID/UNG-dependent pathway of immunoglobulin gene diversification.
###end article-title 95
###begin article-title 96
The Mre11 complex: at the crossroads of dna repair and checkpoint signalling.
###end article-title 96
###begin article-title 97
ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks.
###end article-title 97
###begin article-title 98
Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation.
###end article-title 98
###begin article-title 99
###xml 135 141 <span type="species:ncbi:10090">murine</span>
Conditional gene targeted deletion by Cre recombinase demonstrates the requirement for the double-strand break repair Mre11 protein in murine embryonic stem cells.
###end article-title 99
###begin article-title 100
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice.
###end article-title 100
###begin article-title 101
The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder.
###end article-title 101
###begin article-title 102
Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome.
###end article-title 102
###begin article-title 103
Delineation of the role of the Mre11 complex in class switch recombination.
###end article-title 103
###begin article-title 104
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Alternative end joining during switch recombination in patients with ataxia-telangiectasia.
###end article-title 104
###begin article-title 105
Nibrin functions in Ig class-switch recombination.
###end article-title 105
###begin article-title 106
Genomic instability, endoreduplication, and diminished Ig class-switch recombination in B cells lacking Nbs1.
###end article-title 106
###begin article-title 107
The MRE11-RAD50-NBS1 complex accelerates somatic hypermutation and gene conversion of immunoglobulin variable regions.
###end article-title 107
###begin article-title 108
Somatic mutation hotspots correlate with DNA polymerase eta error spectrum.
###end article-title 108
###begin article-title 109
Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks.
###end article-title 109
###begin article-title 110
Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis.
###end article-title 110
###begin article-title 111
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
DNA polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse.
###end article-title 111
###begin article-title 112
DNA polymerases eta and theta function in the same genetic pathway to generate mutations at A/T during somatic hypermutation of Ig genes.
###end article-title 112
###begin article-title 113
###xml 8 13 <span type="species:ncbi:9606">human</span>
A novel human AP endonuclease with conserved zinc-finger-like motifs involved in DNA strand break responses.
###end article-title 113
###begin article-title 114
###xml 118 122 <span type="species:ncbi:10090">mice</span>
The in vivo pattern of AID targeting to immunoglobulin switch regions deduced from mutation spectra in msh2-/- ung-/- mice.
###end article-title 114
###begin article-title 115
Known components of the immunoglobulin A:T mutational machinery are intact in Burkitt lymphoma cell lines with G:C bias.
###end article-title 115
###begin article-title 116
DNA replication checkpoint.
###end article-title 116
###begin article-title 117
The Mre11 Complex Mediates the S-Phase Checkpoint through an Interaction with Replication Protein A.
###end article-title 117
###begin article-title 118
Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks.
###end article-title 118
###begin article-title 119
ATM and ATR promote Mre11 dependent restart of collapsed replication forks and prevent accumulation of DNA breaks.
###end article-title 119
###begin article-title 120
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Strand-biased defect in C/G transversions in hypermutating immunoglobulin genes in Rev1-deficient mice.
###end article-title 120
###begin article-title 121
AID in somatic hypermutation and class switch recombination.
###end article-title 121
###begin article-title 122
An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele.
###end article-title 122
###begin article-title 123
The NBS1-ATM connection revisited.
###end article-title 123
###begin article-title 124
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder.
###end article-title 124
###begin article-title 125
Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair.
###end article-title 125
###begin article-title 126
The ATM-dependent DNA damage signaling pathway.
###end article-title 126
###begin article-title 127
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Immunoglobulin class switch recombination is impaired in Atm-deficient mice.
###end article-title 127
###begin article-title 128
###xml 99 104 <span type="species:ncbi:9606">human</span>
Impact of DNA ligase IV on nonhomologous end joining pathways during class switch recombination in human cells.
###end article-title 128
###begin article-title 129
ATM is required for efficient recombination between immunoglobulin switch regions.
###end article-title 129
###begin article-title 130
IgH class switching and translocations use a robust non-classical end-joining pathway.
###end article-title 130
###begin article-title 131
ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region.
###end article-title 131
###begin article-title 132
The clinical and biological overlap between Nijmegen Breakage Syndrome and Fanconi anemia.
###end article-title 132
###begin article-title 133
###xml 49 57 <span type="species:ncbi:9606">children</span>
Heterogeneity of humoral immune abnormalities in children with Nijmegen breakage syndrome: an 8-year follow-up study in a single centre.
###end article-title 133
###begin article-title 134
DNA polymerase eta is involved in hypermutation occurring during immunoglobulin class switch recombination.
###end article-title 134
###begin article-title 135
IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis.
###end article-title 135
###begin article-title 136
Disparate roles of ATR and ATM in immunoglobulin class switch recombination and somatic hypermutation.
###end article-title 136
###begin article-title 137
Hypermutation at A-T base pairs: the A nucleotide replacement spectrum is affected by adjacent nucleotides and there is no reverse complementarity of sequences flanking mutated A and T nucleotides.
###end article-title 137
###begin article-title 138
Strand-biased spreading of mutations during somatic hypermutation.
###end article-title 138
###begin p 139
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 139
###begin p 140
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the Swedish Research Council, the Swedish Cancer Foundation, the Swedish Society for Medicine and the "KID" program of the Karolinska Institutet. A. M. Taylor acknowledges the continuing support of CR-UK.
###end p 140

